Mental Health Clinics in Keansburg, NJ Accepting Medicare
6 Mental Health Clinics found. Showing 1 - 6
 Ymca Of Greater Monmouth County Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 140 Port Monmouth Rd, Keansburg, NJ 07734 Phone: 732-290-9040 Fax: 732-566-0433 |
Lets Go Behavior Consulting Behavioral Analyst Medicare: Not Enrolled in Medicare Practice Location: 165 Shore Blvd Apt 1, Keansburg, NJ 07734 Phone: 201-741-2035 |
Ymca Of Greater Monmouth County Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 100 Palmer Pl, Keansburg, NJ 07734 Phone: 732-290-9040 |
Solutions For Growth Social Worker - Clinical Medicare: Not Enrolled in Medicare Practice Location: 40 Carr Ave, Suite C, Keansburg, NJ 07734 Phone: 732-670-7771 Fax: 732-471-6360 |
Ymca Of Greater Monmouth County Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 81 Francis Pl, Keansburg, NJ 07734 Phone: 732-290-9040 |
Monmouth Counseling Program Community/Behavioral Health Agency Medicare: Not Enrolled in Medicare Practice Location: 100 Main St, Monmouth Counseling Program, Keansburg, NJ 07734 Phone: 609-394-3202 Fax: 609-278-6139 |
News Archive
Single dose of Oxford-AstraZeneca vaccine protective in previously infected recipients, suggests study
A recent report on the medRxiv* preprint server suggests that a single dose of the Oxford-AstraZeneca (ChAdOx1 nCoV-19) vaccine could elicit higher titers of neutralizing antibodies, effectively acting as a booster dose, in people who have already been infected by the SARS-CoV-2.
Atrasentan reduces cancer risk by 20 percent in men with advanced hormone-resistant prostate cancer
Recent clinical studies led by Johns Hopkins Kimmel Cancer Center researchers have found that a drug called atrasentan reduces the risk by 20 percent that cancer will progress in men with advanced hormone-resistant prostate cancer.
First Edition: June 1, 2011
Kaiser Health News staff writer Phil Galewitz reports: "Trying to spur enrollment in a key new benefit of the 2010 health law, the Obama administration announced today it is slashing premiums for new high-risk insurance plans and no longer requiring applicants to submit a rejection letter from private insurers".
WHO welcomes SHINE trial results on shorter treatment for drug-susceptible TB in children
The World Health Organization's Global TB Programme welcomes the results from an important study on shortened treatment for drug-susceptible tuberculosis in children, presented at the 51st virtual Union World Conference on Lung Health.
Researchers identify cellular/molecular defect in T cell regulatory pathway
Researchers at Columbia University Medical Center have identified a defect in the T cell regulatory pathway which normally controls autoreactive T cells that attack the body's own tissues and organs. A majority of people with Type 1 diabetes who were tested in the study were found to have the newly-identified cellular/molecular defect, and the researchers were able to successfully correct the defect in-vitro.
› Verified 1 days ago